
Emory begins enrolment for BioCardia’s trial of ischemic heart failure therapy
Emory University School of Medicine, US, has commenced subject enrolment for BioCardia’s Phase III CardiAMP HF II trial of CardiAMP Cell Therapy Product in treating ischemic heart failure. The trial is assessing BioCardia’s lead product candidate for …